日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Maternal Gut Microbiome as a Predictor of Insulin Therapy Requirement in Gestational Diabetes

母体肠道微生物群作为妊娠期糖尿病胰岛素治疗需求的预测指标

Popova, Polina V; Loboda, Alexander A; Liaudanski, Aleh; Sitkin, Stanislav I; Anopova, Anna D; Vasukova, Elena A; O Isakov, Artem; Tkachuk, Alexandra S; Nemikina, Irina S; Akhmatova, Maria; Eriskovskaya, Angelina I; Vasilieva, Elena Y; Galyautdinov, Ilgiz V; Babenko, Alina; Zgairy, Soha; Rubin, Elad; Even, Carmel; Turjeman, Sondra; Pervunina, Tatiana M; Kostareva, Anna A; Vatian, Aleksandra S; Mohan, Viswanathan; Grineva, Elena N; Koren, Omry; Shlyakhto, Evgeny V

Breast Cancer and Cardiovascular Risk: The Role of Dyslipidemia, Inflammation and Obesity

乳腺癌与心血管风险:血脂异常、炎症和肥胖的作用

Loboda, Barbara; Zdravkovic, Darko; Ivanovic, Nebojsa; Colakovic, Natasa; Petricevic, Simona; Gojgic, Milan; Crnokrak, Bogdan; Milosavljevic, Vladimir; Popadic, Viseslav; Bjelica, Dragana; Stojanovic, Visnja; Zdravković, Marija

Predictive Factors of Early and One-Year Mortality in Patients with Acute Pancreatitis

急性胰腺炎患者早期及一年死亡率的预测因素

Sekulic, Ana; Marinkovic, Olivera; Nikolic, Novica; Brajkovic, Milica; Loboda, Barbara; Aleksijevic, Teodora; Gacic, Jasna; Nadj, Igor; Guslarevic, Stefan; Milic, Danilo; Trpkovic, Sladjana; Pavlovic, Aleksandar; Zdravkovic, Darko

Transvenous Lead Extraction Complicated by Lead Breakage: A Predictive Model Based on Analysis of the EXTRACT Registry

经静脉导线拔除术并发导线断裂:基于 EXTRACT 注册研究分析的预测模型

Joniec, Michal; Stachanczyk, Joanna; Gardas, Rafal; Gladysz-Wanha, Sylwia; Pilat, Eugeniusz; Drzewiecka, Anna; Biernat, Jolanta; Weglarzy, Andrzej; Wanha, Wojciech; Loboda, Danuta; Golba, Krzysztof S

Cancer-Associated Thrombosis in Breast Cancer: Risk Factors and Personalized Management

乳腺癌相关血栓形成:风险因素和个体化管理

Kozhukhov, Sergey; Dovganych, Nataliia; Lygyrda, Olha; Smolanka, Ivan; Loboda, Anton; Lyalkin, Sergii

Pembrolizumab plus axitinib versus sunitinib for advanced clear cell renal cell carcinoma: 5-year survival and biomarker analyses of the phase 3 KEYNOTE-426 trial

帕博利珠单抗联合阿昔替尼对比舒尼替尼治疗晚期透明细胞肾细胞癌:KEYNOTE-426 III期试验的5年生存率和生物标志物分析

Rini, Brian I; Plimack, Elizabeth R; Stus, Viktor; Gafanov, Rustem; Waddell, Tom; Nosov, Dmitry; Pouliot, Frédéric; Alekseev, Boris; Soulières, Denis; Melichar, Bohuslav; Vynnychenko, Ihor; de Azevedo, Sergio Jobim; Borchiellini, Delphine; McDermott, Raymond S; Bedke, Jens; Tamada, Satoshi; Wu, Sterling; Markensohn, Julia; Zhang, Yiwei; Loboda, Andrey; Vajdi, Amir; Perini, Rodolfo F; Burgents, Joseph; Powles, Thomas

Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer

将脂质组学与靶向、单细胞和空间转录组学相结合,揭示了结肠癌中尚未解决的促炎状态。

Soundararajan, Ramani; Maurin, Michelle M; Rodriguez-Silva, Jetsen; Upadhyay, Gunjan; Alden, Ashley J; Gowda, Siddabasave Gowda B; Schell, Michael J; Yang, Mingli; Levine, Noah Jhad; Gowda, Divyavani; Sundaraswamy, Punith M; Hui, Shu-Ping; Pflieger, Lance; Wang, Heiman; Marcet, Jorge; Martinez, Carolina; Bennett, Robert David; Chudzinski, Allen; Karachristos, Andreas; Nywening, Timothy M; Cavallaro, Paul M; Anderson, Matthew Linley; Coffey, Robert J; Nebozhyn, Michael V; Loboda, Andrey; Coppola, Domenico; Pledger, Warren Jackson; Halade, Ganesh V; Yeatman, Timothy J

High 4E-BP1 expression associates with chromosome 8 gain and CDK4/6 sensitivity in Ewing sarcoma

尤文氏肉瘤中高表达的 4E-BP1 与 8 号染色体扩增和 CDK4/6 敏感性相关

Funk, Cornelius M; Ehlers, Anna C; Orth, Martin F; Aljakouch, Karim; Li, Jing; Hölting, Tilman Lb; Will, Rainer; Geyer, Florian H; Ceranski, A Katharina; Willis, Franziska; Vinca, Endrit; Ohmura, Shunya; Imle, Roland; Siebenlist, Jana; Yershova, Angelina; Knott, Maximilian Ml; Zahnow, Felina; Sastre, Ana; Alonso, Javier; Sahm, Felix; Peterziel, Heike; Loboda, Anna; Schneider, Martin; Banito, Ana; Leprivier, Gabriel; Hartmann, Wolfgang; Dirksen, Uta; Witt, Olaf; Oehme, Ina; Pfister, Stefan M; Romero-Pérez, Laura; Krijgsveld, Jeroen; Cidre-Aranaz, Florencia; Grünewald, Thomas Gp; Musa, Julian

Development and Application of Small Molecule-Peptide Conjugates as Cathepsin K-Specific Covalent Irreversible Inhibitors in Human Osteoclast and Lung Cancer.

小分子肽缀合物作为组织蛋白酶 K 特异性共价不可逆抑制剂在人类破骨细胞和肺癌中的开发与应用

Dey Gourab, Yakobovich Evalyn, Loboda Jure, Sinai-Turyansky Reut, Abramovitch-Dahan Chen, Merquiol Emmanuelle, Sridharan Nikhila, Itzhak Gal, Turk Boris, Wald Ori, Turk Dusan, Yona Simon, Levaot Noam, Blum Galia

Association of potential biomarkers with clinical outcomes in metastatic triple-negative breast cancer treated with pembrolizumab or chemotherapy

潜在生物标志物与接受帕博利珠单抗或化疗治疗的转移性三阴性乳腺癌临床结局的关联

Cortes, Javier; Lipatov, Oleg; Im, Seock-Ah; Goncalves, Anthony; Lee, Keun Seok; Schmid, Peter; Tamura, Kenji; Testa, Laura; Ohtani, Shoichiro; Harbeck, Nadia; Loi, Sherene; Salgado, Roberto; Karantza, Vassiliki; Mejia, Jaime; Cristescu, Razvan; Loboda, Andrey; Nebozhyn, Michael; Jelinic, Petar; Huang, Lingkang; Winer, Eric P